The effect of aspirin on thrombin stimulated platelet adhesion receptor expression and the role of neutrophils

British Journal of Clinical Pharmacology

Volumn 46, Issue 2, 1998, Pages 139-145

  Taylor, Marcia L ^a,c   Ilton, Marcus K ^a   Misso, Neil L A ^a   Watkins, D Neil ^a   Hung, Joseph ^a   Thompson, Philip J ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

^c JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

Aspirin; GPIIb IIIa; Neutrophil; Nitric oxide; P selectin; Platelet

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOGEN RECEPTOR; NITRIC OXIDE; PADGEM PROTEIN; THROMBIN;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

ADULT; ASPIRIN; BLOOD PLATELETS; FEMALE; HUMANS; MALE; NEUTROPHILS; NITRIC OXIDE; NITRITES; P-SELECTIN; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; THROMBIN;

EID: 0031830306     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1998.00766.x     Document Type: Article

References (46)

1. Pedersen AK, Fitzgerald GA. Dose-related kinetics of aspirin. N Engl J Med 1984; 311: 1206-1211.
2. Patrono C. Drug therapy: Aspirin as an anti-platelet drug. N Engl J Med 1994; 330: 1287-1294.
3. Gaspari F, Vigano G, Orisio S, Bonati M, Livio M, Remuzzi G, Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition. J Clin Invest 1987; 79: 1788-1797.
4. Mehta P, Mehta JL. Effects of aspirin in arterial thrombosis: why don't animals behave the way humans do? J Am Coll Cardiol 1993; 21: 502-510.
5. Valles J, Santos MT, Marcus AJ, et al. Downregulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins. J Clin Invest 1993; 92: 1357-1365.
6. Lopez-Farre A, Caramelo C, Esteban A, et al. Effects of aspirin on platelet-neutrophil interactions: role of nitric oxide and endothelin-1. Circulation 1995; 91: 2080-2088.
7. 2 formation. N Engl J Med 1988; 319: 689-698.
8. Taylor ML, Misso NLA, Stewart GA, Thompson PJ. The effects of varying doses of aspirin on human platelet activation induced by PAF, collagen and arachidonic acid, Br J Clin Pharmacol 1992; 33: 25-31.
9. Marcus AJ. Neutrophils inhibit platelet reactivity by multiple mechanisms: relevance to thromboregulation. J Lab Clin Med 1990; 116: 138-139.
10. Dinerman JL, Mehta JL. Endothelial, platelet and leukocyte interactions in ischemic heart disease: insights into potential mechanisms and their clinical relevance. J Am Coll Caradiol 1990; 16: 207-222.
11. Del Maschio A, Dejana E, Bazzoni G. Bidirectional modulation of platelet and polymorphonuclear leukocyte activities. Ann Hematol 1993; 67: 23-31.
12. Cerletti C, Evangelista V, Molino M, de Gaetano G. Platelet activation by polymorphonuclear leukocytes: role of cathepsin G and P-selectin. Thromb Haemost 1995; 74: 218-223.
13. Faint RW, Mackie IJ, Machin SJ. Platelet aggregation is inhibited by a nitric oxide-like factor released from human neutrophils in vitro. Br J Haematol 1991; 77: 539-545.
14. Atkinson DC, Collier HOJ. Salicylates: molecular mechanism of therapeutic action. Adv Pharmacol Chemother 1980; 17: 233-240.
15. Handin RI, Karabon R, Boxer GJ. Enhancement of platelet function by Superoxide anion. J Clin Invest 1977; 59: 959-965.
16. Salvemini D, de Nucci G, Sneddon JM, Vane JR. Superoxide anions enhance platelet adhesion and aggregation. Br J Pharmacol 1989; 97: 1145-1150.
17. Selak MA, Chignard M, Smith JB. Cathepsin G is a strong platelet agonist released by neutrophils. Biochem J 1988; 251: 293-299.
18. Del Maschio A, Evangelista V, Rajtar G, Chen ZM, Cerletti C, de Gaetano G. Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents. Am J Physiol 1990; 258: H870-H879.
19. Evangelista V, Rajtar G, de Gaetano G, White JG, Cerletti C. Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinases. Blood 1991; 77: 2379-2388.
20. Zatta A, Prosdocimi M, Bertele V, Bazzom G, Del Maschio A. Inhibition of platelet function by polymorphonuclear leukocytes. J Lab Clin Med 1990; 116: 651-660.
21. Nicolini FA, Wilson AC, Mehta P, Mehta JL. Comparative platelet inhibitory effects of human neutrophils and lymphocytes. J Lab Clin Med 1990; 116: 147-152.
22. Faint RW. Platelet-neutrophil interactions: their significance. Blood Reviews 1992; 6: 83-91.
23. Schattner MA, Finiasz MR, Notrica JA, Lazzan MA. Platelet aggregation inhibition by mononuclear leukocytes, Thromb Res 1994; 73: 205-214.
24. Taylor ML, Misso NLA, Stewart GA, Thompson PJ. Differential expression of platelet activation markers CD62P and CD63 following stimulation with PAF, arachidonic acid and collagen. Platelets 1995; 6: 394-401.
25. Hamburger SA, McEver RP. GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood 1990; 75: 550-554.
26. Polley MJ, Phillips ML, Wayner E, et al. CD62 and endothelial cell-leukocyte adhesion molecule 1 (ELAM-1) recognize the same carbohydrate ligand, sialyl-Lewis x. Proc Natl Acad Sci USA 1991; 88: 6224-6228.
27. Furie B, Furie BC. The molecular basis of platelet and endothelial cell interaction with neutrophils and monocytes: role of P-selectin and the P-selectin ligand, PSGL-1. Thromb Haemost 1995; 74: 224-227.
28. Nagata K, Tsuji T, Todoroki N, et al. Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin (CD62). J Immunol 1993; 151: 3267-3273.
29. 4 cooperative synthesis. Thromb Haemost 1994; 72: 450-456.
30. Pytela R, Piercshbacher MD, Ginsberg MH, Plow EF, Ruoslahti E. Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp specific adhesion receptors. Science 1986; 231: 1559-1562.
31. Phillips DR, Charo IF, Panse LV, Fitzgerald LA. The platelet membrane glycoprotein IIb-IIIa complex. Blood 1988; 71: 831-843.
32. Rinder LS, Student LA, Bonan JL, Rinder HM, Smith BR. Aspirin does not inhibit adenosine diphosphate-induced platelet alpha granule release. Blood 1993; 82: 505-512.
33. Taylor ML, Stewart GA, Thompson PJ. The differential effect of aspirin on human platelet activation in aspirin-sensitive asthmatics and normal subjects. Br J Clin Pharmacol 1993; 35: 227-234.
34. Taylor ML, Misso NLA, Stewart GA, Thompson PJ. Differential expression of platelet activation markers in aspirin-sensitive asthmatics and normal subjects. Clin Exp Allergy 1996; 26: 202-215.
35. 15N nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
36. Hung J, Lam JY, Lacoste L, Letchacovski G. Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circulation 1995; 92: 2432-2436.
37. Chronos NAF, Wilson DJ, Janes SL, Hutton RA, Buller NP, Goodall AH. Aspirin does not affect the flow cytometric detection of fibrinogen binding to, or release of α-granules or lysosomes from human platelets. Clin Sci 1994; 87: 575-580.
38. Peng J, Friese P, Heilmann E, George JN, Burstein SA, Dale GL. Aged platelets have an impaired response to thrombin as quantitated by P-selectin expression. Blood 1994; 83: 161-166.
39. Thornton MA, Gruentzig AR, Hollman J, King SB, Douglas JS. Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study. Circulation 1984; 69: 721-727.
40. Schwartz L, Bourassa MG, Lesperance J, et al. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 1988; 318: 1714-1719.
41. Davies MJ. Mechanisms of thrombosis in atherosclerosis. In Hemostasis and Trombosis: Basic Principles and Clinical Practice, Third Edition, eds Colman RW, Hirsh J, Marder VJ, Salzman EW, Philadelphia: JB Lippincott, 1994: 1224-1237.
42. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-141.
43. Radomski MW, Palmer RMJ, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 1987; 92: 181-187.
44. Szczeklik A, Krzanowski M, Gora P, Radwan J. Antiplatelet drugs and generation of thrombin in clotting blood. Blood 1992; 80: 2006-2011.
45. Watala C, Gwozdzinski K. Effect of aspirin on conformation and dynamics of membrane proteins in platelets and erythrocytes. Biochem Pharmacol 1993; 45: 1343-1349.
46. Diaz-Gonzalez F, Gonzalez-Alvaro I, Campanero MR, et al. Prevention of in vitro neutrophil-endothelial attachment through shedding of L-selectin by nonsteroidal anti-inflammatory drugs. J Clin Invest 1995; 95: 1756-1765.